PortfoliosLab logoPortfoliosLab logo
Shattuck Labs, Inc. (STTK)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US82024L1035
CUSIP
82024L103
IPO Date
Oct 9, 2020

Highlights

EPS (TTM)
-$0.89
Total Revenue (TTM)
$1.00M
Gross Profit (TTM)
-$865.00K
EBITDA (TTM)
-$52.82M
Year Range
$0.69 - $6.81
Target Price
$10.50
ROA (TTM)
-60.31%
ROE (TTM)
-66.63%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Shattuck Labs, Inc.

Often compared with STTK:
STTK vs. QBTSSTTK vs. BDTXSTTK vs. EQ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Shattuck Labs, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Shattuck Labs, Inc. (STTK) has returned 76.16% so far this year and 576.77% over the past 12 months.


Shattuck Labs, Inc.

1D
7.89%
1M
64.03%
YTD
76.16%
6M
169.04%
1Y
576.77%
3Y*
29.80%
5Y*
-26.31%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Oct 9, 2020, STTK's average daily return is +0.15%, while the average monthly return is +4.97%. At this rate, your investment would double in approximately 1.2 years.

Historically, 45% of months were positive and 55% were negative. The best month was Dec 2023 with a return of +263.8%, while the worst month was Oct 2024 at -63.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 5 months.

On a daily basis, STTK closed higher 47% of trading days. The best single day was Dec 13, 2023 with a return of +130.3%, while the worst single day was Oct 1, 2024 at -45.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20266.03%1.29%64.03%76.16%
2025-4.13%13.79%-28.02%4.09%2.12%-21.60%-3.81%28.78%143.68%-19.67%9.37%73.81%201.65%
202432.40%-7.52%2.41%17.23%-29.58%-47.70%3.11%-9.80%-2.79%-63.90%-12.70%10.00%-83.03%
202381.30%13.19%-37.71%2.04%-7.67%12.64%-18.27%-15.29%-29.63%6.58%20.99%263.78%210.00%
2022-18.80%-27.64%-14.80%-9.86%-25.52%41.96%-6.16%-14.70%-16.92%-1.85%-14.34%1.32%-72.97%
2021-5.34%-16.75%-29.20%28.86%-27.97%6.82%-23.97%-4.13%-3.55%-5.30%-56.06%0.35%-83.76%

Benchmark Metrics

Shattuck Labs, Inc. has an annualized alpha of 24.28%, beta of 1.28, and R² of 0.03 versus S&P 500 Index. Calculated based on daily prices since October 12, 2020.

  • This stock participated in 137.07% of S&P 500 Index downside but only 17.65% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.03 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
24.28%
Beta
1.28
0.03
Upside Capture
17.65%
Downside Capture
137.07%

Return for Risk

Risk / Return Rank

STTK ranks 97 for risk / return — in the top 97% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.


STTK Risk / Return Rank: 9797
Overall Rank
STTK Sharpe Ratio Rank: 9999
Sharpe Ratio Rank
STTK Sortino Ratio Rank: 9797
Sortino Ratio Rank
STTK Omega Ratio Rank: 9595
Omega Ratio Rank
STTK Calmar Ratio Rank: 9999
Calmar Ratio Rank
STTK Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Shattuck Labs, Inc. (STTK) and compare them to a chosen benchmark (S&P 500 Index).


STTKBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

4.26

0.90

+3.36

Sortino ratio

Return per unit of downside risk

4.06

1.39

+2.68

Omega ratio

Gain probability vs. loss probability

1.52

1.21

+0.31

Calmar ratio

Return relative to maximum drawdown

11.66

1.40

+10.26

Martin ratio

Return relative to average drawdown

22.71

6.61

+16.10

Explore STTK risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Shattuck Labs, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Shattuck Labs, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Shattuck Labs, Inc. was 98.73%, occurring on Aug 1, 2025. The portfolio has not yet recovered.

The current Shattuck Labs, Inc. drawdown is 88.84%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-98.73%Dec 28, 20201154Aug 1, 2025
-18.92%Nov 5, 20204Nov 10, 20202Nov 12, 20206
-18.09%Dec 1, 20202Dec 2, 20206Dec 10, 20208
-13.19%Dec 11, 20202Dec 14, 20204Dec 18, 20206
-6.54%Nov 18, 20201Nov 18, 20202Nov 20, 20203

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Shattuck Labs, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Shattuck Labs, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for STTK relative to other companies in the Biotechnology industry. Currently, STTK has a P/S ratio of 396.0. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items